Donald Y M Leung1. 1. Edelstein Family Chair of Pediatric Allergy-Immunology, National Jewish Health, Denver, Colorado, USA and Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology, The 2nd Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Abstract
PURPOSE OF REVIEW: The review will examine recent advances in our understanding of atopic dermatitis and how these mechanisms provide a framework for new approaches to the management of this common skin disease. RECENT FINDINGS: The mechanisms by which epithelial skin barrier and immune responses contribute to the complex clinical phenotypes found in atopic dermatitis are being elucidated. Atopic dermatitis often precedes food allergy because reduced skin barrier function allows environmental food allergens to penetrate the skin leading to systemic allergen sensitization. There is increasing evidence that atopic dermatitis is a systemic disease. New treatments are focused on intervention in polarized immune responses leading to allergic diseases. This includes antagonism of IL-4 and IL-13 effects. Prevention strategies involve maintaining normal skin barrier function with emollients to prevent allergens and microbes from penetrating the skin. SUMMARY: Recent work on the pathogenesis of atopic dermatitis has important implications for its clinical management, including the development of effective barrier creams and biologicals targeting specific polarized immune pathways resulting in skin inflammation.
PURPOSE OF REVIEW: The review will examine recent advances in our understanding of atopic dermatitis and how these mechanisms provide a framework for new approaches to the management of this common skin disease. RECENT FINDINGS: The mechanisms by which epithelial skin barrier and immune responses contribute to the complex clinical phenotypes found in atopic dermatitis are being elucidated. Atopic dermatitis often precedes food allergy because reduced skin barrier function allows environmental food allergens to penetrate the skin leading to systemic allergen sensitization. There is increasing evidence that atopic dermatitis is a systemic disease. New treatments are focused on intervention in polarized immune responses leading to allergic diseases. This includes antagonism of IL-4 and IL-13 effects. Prevention strategies involve maintaining normal skin barrier function with emollients to prevent allergens and microbes from penetrating the skin. SUMMARY: Recent work on the pathogenesis of atopic dermatitis has important implications for its clinical management, including the development of effective barrier creams and biologicals targeting specific polarized immune pathways resulting in skin inflammation.
Authors: Michelle G Filanovsky; Suwimon Pootongkam; Joan E Tamburro; Mary C Smith; Stephen J Ganocy; Susan T Nedorost Journal: J Pediatr Date: 2015-11-23 Impact factor: 4.406
Authors: Helen A Brough; Andrew H Liu; Scott Sicherer; Kerry Makinson; Abdel Douiri; Sara J Brown; Alick C Stephens; W H Irwin McLean; Victor Turcanu; Robert A Wood; Stacie M Jones; Wesley Burks; Peter Dawson; Donald Stablein; Hugh Sampson; Gideon Lack Journal: J Allergy Clin Immunol Date: 2014-11-18 Impact factor: 10.793
Authors: Lieneke F M Ariëns; Daphne S Bakker; Jorien van der Schaft; Floor M Garritsen; Judith L Thijs; Marjolein S de Bruin-Weller Journal: Ther Adv Chronic Dis Date: 2018-05-11 Impact factor: 5.091
Authors: Petra Pavel; Géraldine Leman; Martin Hermann; Christian Ploner; Thomas O Eichmann; Deborah Minzaghi; Franz P W Radner; Barbara Del Frari; Robert Gruber; Sandrine Dubrac Journal: JID Innov Date: 2021-06-15